Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro

被引:80
|
作者
Shapiro, L
Heidenreich, KA
MEintzer, MK
Dinarello, CA
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[3] Denver Vet Affairs Med Ctr, Denver, CO 80262 USA
关键词
interleukin; 1;
D O I
10.1073/pnas.95.13.7422
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The proinflammatory cytokines interleukin (LL)-1 and tumor necrosis factor (TNF) promote HIV type 1 viral replication in vitro. In the present studies, HIV production was increased in the macrophagic U1 cell line expressing the HIV genome after exposure to IL-1 beta, osmotic stress, or surface adhesion, suggesting a confluence of signaling pathways for proinflammatory cytokines and cell stressors. The p38 mitogen-activated protein kinase (MAPK) mediates both cytokine and stress responses; thus the role of this kinase in HIV production was investigated. HIV production as measured by p24 antigen correlated with changes in the expression of a specific (non-alpha) isoform of p38 MAPK. In the presence of a specific p38 MAPK inhibitor (p38 inh), IL-1 beta-induced HIV production was suppressed by more than 90% and IL-1 beta-induced IL-8 production was suppressed completely, both with IC50 of 0.01 mu M. p38 inhibition blocked cell-associated p24 antigen and secreted virus to a similar extent. The p38 inh also decreased constitutive HIV production in freshly infected peripheral blood mononuclear cells by up to 50% (P < 0.05:. Interruption of p38 MAPK activity represents a viable target for inhibition of HIV.
引用
收藏
页码:7422 / 7426
页数:5
相关论文
共 50 条
  • [21] P38 mitogen-activated protein kinase regulates myelination
    Haines, Jeffery D.
    Fragoso, Gabriela
    Hossain, Shireen
    Mushynski, Walter E.
    Almazan, Guillermina
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 35 (01) : 23 - 33
  • [22] Mitogen-Activated Protein Kinase p38 in HIV Infection and Associated Brain Injury
    Medders, Kathryn E.
    Kaul, Marcus
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 (02) : 202 - 215
  • [23] Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
    Bassi, Rekha
    Burgoyne, Joseph R.
    DeNicola, Gian F.
    Rudyk, Olena
    DeSantis, Vittorio
    Charles, Rebecca L.
    Eaton, Philip
    Marber, Michael S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (39) : 16161 - 16173
  • [24] Mitogen-Activated Protein Kinase p38 in HIV Infection and Associated Brain Injury
    Kathryn E. Medders
    Marcus Kaul
    Journal of Neuroimmune Pharmacology, 2011, 6 : 202 - 215
  • [25] Inhibitors of P38 mitogen-activated protein kinase promote neuronal survival in vitro
    Horstmann, S
    Kahle, PJ
    Borasio, GD
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 204 - 204
  • [26] Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro
    Horstmann, S
    Kahle, PJ
    Borasio, GD
    JOURNAL OF NEUROSCIENCE RESEARCH, 1998, 52 (04) : 483 - 490
  • [27] p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles
    Curti, A. M.
    Wilkinson, P. F.
    Gui, M.
    Gales, T. L.
    Hu, E.
    Edelberg, J. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 701 - 709
  • [28] The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease
    Feng, Ya Jing
    Li, Yong Yu
    JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (05) : 327 - 332
  • [29] Role of p38 α mitogen-activated protein kinase in lung metastasis of tumor cells
    Kasuya, Yoshitoshi
    Matsuo, Yuji
    Amano, Shinya
    Furuya, Mitsuko
    Namiki, Kana
    Sakurai, Kanako
    Nishiyama, Mariko
    Sudo, Tatsuhiko
    Tatsumi, Koichtro
    Kuriyama, Takayuki
    Kimura, Sadao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 118P - 118P
  • [30] Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation
    Nick, JA
    Young, SK
    Brown, KK
    Avdi, NJ
    Arndt, PG
    Suratt, BT
    Janes, MS
    Henson, PM
    Worthen, GS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (04): : 2151 - 2159